NovaBay Pharmaceuticals, Inc. engages in the development and sales of scientifically-created and clinically-proven eyecare and skincare. The company is headquartered in Emeryville, California and currently employs 14 full-time employees. The company went IPO on 2007-10-26. The firm manufactures and sells its proprietary form of hypochlorous acid for the wound care market through its NeutroPhase and PhaseOne branded products. NeutroPhase and PhaseOne are used for cleansing and irrigation as part of surgical procedures, as well as treating wounds, burns, ulcers and other injuries.
NBY stock price ended at $0 on Cuma, after dropping NaN%
On the latest trading day Aug 07, 2026, the stock price of NBY fell by NaN%, dropping from $NaN to $NaN. During the session, the stock saw a volatility of NaN%, with prices oscillating between a daily low of $NaN and a high of $NaN. On the latest trading day, the trading volume for NBY decreased by -- shares, aligning with the declining prices, which may indicate weakening market confidence in the near term. In total, -- shares were traded, with a market value of approximately --.
NBYTeknik Sinyalleri
Teknik Sinyaller Özeti
Satın Alma Sinyalleri 0
Nötr Sinyaller 7
Satış Sinyalleri 0
Strong Sell
Sell
Neutral
Buy
Strong Buy
NBY, şu anda 0 alım sinyali ve 0 satım sinyali vermektedir. Hisse senedi --'ten beri Aşağı yönlü trend durumundadır ve bu dönemde toplam -- fiyat değişimi gerçekleşti. Genel olarak teknik göstergeler orta vadeli olarak Neutral görünüm işaret etmektedir.
NBY için Boğa/Ayı Sinyalleri
Hareketli ortalamalar, RSI, MACD ve işlem hacmi gibi temel göstergeleri analiz ederek NBY için yükseliş ve düşüş sinyalleri üretiyoruz. Bu analizlerle daha bilinçli yatırım kararları verin.